GO:0000502 proteasome complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000502 (proteasome complex) is a large multisubunit ATP-dependent protease that catalyzes protein degradation in eukaryotes, archaea and some bacteria.
• The eukaryotic 26S proteasome consists of a barrel-shaped 20S core complex capped by one or two 19S regulatory particles that control substrate entry and exit.
• Proteasome-mediated degradation regulates cell cycle progression, apoptosis, signal transduction, antigen presentation and protein quality control.
• Proteasome inhibitors such as bortezomib are clinically used in multiple myeloma and mantle cell lymphoma, validating the complex as a drug target.
• Assembly of the 20S core requires dedicated chaperones (PAC1-PAC4, POMP, UMP1) and is a highly ordered process.
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal dissection of proteasome subunit function in disease.
Description
The proteasome complex (GO:0000502) is a large multisubunit protease that catalyzes the majority of regulated protein degradation in eukaryotic cells. It is essential for maintaining protein homeostasis, degrading damaged or misfolded proteins, and controlling the half-life of short-lived regulatory proteins such as cyclins, transcription factors and tumor suppressors. The complex is conserved across eukaryotes, archaea and some bacteria, underscoring its fundamental biological importance. In eukaryotes, the 26S proteasome is composed of a barrel-shaped 20S core complex and one or two 19S regulatory particles that recognize ubiquitinated substrates and regulate entry into the catalytic chamber. Because of its central role in cellular regulation, the proteasome is a major focus in cancer biology, neurodegeneration, immunology and drug discovery. Researchers studying GO:0000502 need reliable tools to manipulate proteasome subunit genes and measure degradation activity, making CRISPR-based models and proteomic methods indispensable.
proteasome complex At A Glance
| GO ID | GO:0000502 |
|---|---|
| GO term | proteasome complex |
| Ontology | cellular_component |
| Synonym | 26S proteasome, proteasome |
| Major function | ATP-dependent degradation of ubiquitinated and non-ubiquitinated proteins |
| Subunits | 20S core (alpha and beta subunits) and 19S regulatory particle (base and lid) |
| Cellular location | Cytoplasm and nucleus; can associate with the endoplasmic reticulum and nuclear envelope |
| Conservation | Eukaryotes, archaea and some bacteria |
| Assembly chaperones | PAC1-PAC4, POMP, UMP1 and others |
What Is GO:0000502?
GO:0000502 (proteasome complex) is defined by QuickGO as a large multisubunit complex that catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel-shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core. The term encompasses both the 20S catalytic core and the 19S regulatory particle, collectively forming the 26S proteasome.
Why Is proteasome complex Important in Cell Biology?
The proteasome complex is essential for protein homeostasis and the regulated degradation of key signaling molecules, making it central to cell cycle control, apoptosis, immune surveillance and stress responses. Dysregulation of proteasome function is implicated in cancer, neurodegenerative diseases and immune disorders, and proteasome inhibitors are approved therapies for hematological malignancies. Understanding its structure, assembly and regulation is therefore critical for both basic biology and therapeutic development.
• Controls degradation of cyclins and CDK inhibitors, thereby regulating cell cycle progression.
• Degrades misfolded and damaged proteins, contributing to protein quality control.
• Generates peptides for MHC class I antigen presentation in immune surveillance.
• Regulates NF-kB signaling by degrading IkB, affecting inflammation and survival.
• Its inhibition is a validated strategy in multiple myeloma and mantle cell lymphoma.
• Mutations in proteasome subunits or assembly chaperones cause autoinflammatory and neurodegenerative disorders.
• Proteasome dynamics and localization change during stress and aging.
• It is a target for drug discovery, including covalent and non-covalent inhibitors.
• Proteasome activity declines with age, contributing to proteostasis collapse.
• CRISPR screens have identified proteasome subunits as essential genes in many cancer cell lines.
What Happens During proteasome complex?
Substrate Recognition and Ubiquitination
In simple terms: Proteins destined for destruction are first tagged with a chain of ubiquitin molecules.
The 26S proteasome degrades proteins that are typically modified with a polyubiquitin chain. Ubiquitin ligases attach ubiquitin to lysine residues on target proteins, and the 19S regulatory particle recognizes these tags. This step ensures selectivity and prevents uncontrolled degradation of cellular proteins.
ATP-Dependent Unfolding and Translocation
In simple terms: The proteasome uses energy to unfold the tagged protein and thread it into the core.
The 19S regulatory particle contains ATPases (Rpt1-6) that unfold substrates and translocate them into the 20S core in an ATP-dependent manner. The base of the 19S particle also contains deubiquitinating enzymes that remove ubiquitin chains before translocation.
Proteolysis in the 20S Core
In simple terms: Inside the barrel, the protein is chopped into small peptides.
The 20S core complex is a barrel-shaped structure composed of four stacked rings: two outer alpha rings and two inner beta rings. The beta subunits (beta1, beta2, beta5) contain the catalytic threonine residues that cleave peptide bonds. The alpha rings form a gate that controls access to the catalytic chamber.
Peptide Release and Recycling
In simple terms: The resulting peptides are released and ubiquitin is recycled.
After cleavage, peptides of 3-25 amino acids are released from the core and can be further degraded by cytosolic peptidases or presented by MHC class I molecules. Ubiquitin molecules are recycled by deubiquitinating enzymes associated with the 19S particle.
Key Genes Involved in GO:0000502 proteasome complex
The following genes encode core subunits, regulatory particle components and assembly chaperones of the proteasome complex (GO:0000502).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSMA1 | 20S core alpha subunit | Structural integrity of the alpha ring; knockout affects core assembly |
| PSMB5 | 20S core beta subunit (catalytic) | Chymotrypsin-like activity; target of bortezomib |
| PSMB6 | 20S core beta subunit (catalytic) | Caspase-like activity; involved in peptide cleavage |
| PSMB7 | 20S core beta subunit (catalytic) | Trypsin-like activity; essential for core function |
| PSMC1 | 19S base ATPase | ATP-dependent unfolding and translocation |
| PSMD1 | 19S lid subunit | Substrate recognition and deubiquitination |
| POMP | 20S assembly chaperone | Required for core particle maturation |
| PSMG1 | 20S assembly chaperone (PAC1) | Assists alpha ring formation |
| PSMG2 | 20S assembly chaperone (PAC2) | Assists beta ring formation |
| PSMG3 | 20S assembly chaperone (PAC3) | Stabilizes assembly intermediates |
| PSMG4 | 20S assembly chaperone (PAC4) | Required for efficient assembly |
| UMP1 | 20S assembly chaperone | Coordinates propeptide processing |
| PSMD14 | 19S deubiquitinase | Removes ubiquitin chains before translocation |
| ADRM1 | 19S ubiquitin receptor | Binds ubiquitinated substrates |
| PSMD4 | 19S ubiquitin receptor | Recognizes polyubiquitin chains |
| PSME1 | 11S regulator (PA28alpha) | Alternative cap that enhances peptide production |
| PSME2 | 11S regulator (PA28beta) | Immunoproteasome regulator |
| PSMB8 | Immunoproteasome beta subunit | Induced by interferon-gamma; antigen presentation |
How Is proteasome complex Regulated?
Proteasome complex activity is regulated at multiple levels. Transcription of proteasome subunit genes is controlled by the transcription factor Nrf1 (NFE2L1) in response to proteasome inhibition, a process known as the proteasome bounce-back response. The mTOR pathway promotes protein synthesis and can indirectly affect proteasome load. Post-translational modifications, including phosphorylation and ubiquitination of subunits, modulate proteasome assembly and activity. Additionally, proteasome localization and dynamics change during stress, aging and disease.
proteasome complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSMB5 | Bortezomib resistance in multiple myeloma | Point mutation knock-in (e.g., A49T) in myeloma cell lines |
| PSMB8 | Autoinflammation (CANDLE syndrome) | Knockout or point mutation in immune cells |
| PSMD1 | Cancer cell proliferation | CRISPR knockout in cancer cell lines |
| POMP | Proteasome assembly defect | Knockout and rescue with wild-type or mutant POMP |
| PSMC1 | Neurodegeneration | Conditional knockout in neurons |
Cancer
Proteasome inhibitors such as bortezomib and carfilzomib are approved for multiple myeloma and mantle cell lymphoma, demonstrating the clinical relevance of the proteasome complex. Cancer cells often depend on high proteasome activity to manage proteotoxic stress, and CRISPR screens have identified proteasome subunits as essential genes in many cancer models.
Neurodegeneration
Impaired proteasome function contributes to the accumulation of misfolded proteins in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Proteasome dynamics and activity decline with age, exacerbating proteostasis collapse.
Autoinflammatory and Immune Disorders
Mutations in immunoproteasome subunits (e.g., PSMB8) cause autoinflammatory syndromes characterized by skin lesions and fever. The proteasome also generates peptides for MHC class I presentation, linking it to immune surveillance.
From proteasome complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PSMB5 affect cell viability? | CRISPR knockout in cancer cell lines |
| Does a specific point mutation confer drug resistance? | Point mutation knock-in (e.g., PSMB5 A49T) |
| How does tagged PSMA1 localize in live cells? | Knock-in of fluorescent tag (e.g., GFP) |
| What is the effect of proteasome subunit overexpression? | Overexpression via lentiviral transduction |
| Which genes regulate proteasome assembly? | CRISPR library screening |
| How does proteasome inhibition alter the proteome? | Proteomics after knockout or inhibitor treatment |
How to Study the proteasome complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Subunit composition and modifications | Proteasome interactome |
| Fluorogenic peptide assay | Catalytic activity | Inhibitor testing |
| CRISPR knockout screen | Gene essentiality | Identify proteasome dependencies |
| Fluorescence microscopy | Localization and dynamics | Live-cell imaging |
| RNA-seq | Transcriptional response | Proteasome bounce-back |
| Western blot | Protein levels and ubiquitin conjugates | Proteasome inhibition |
| Immunoprecipitation | Protein-protein interactions | Assembly intermediates |
Proteomics and Mass Spectrometry
Mass spectrometry-based proteomics enables comprehensive analysis of proteasome complex composition, post-translational modifications and interacting proteins. Affinity purification followed by mass spectrometry can identify subunit stoichiometry and assembly intermediates.
Activity Assays
Fluorogenic peptide substrates measure chymotrypsin-like, trypsin-like and caspase-like activities of the 20S core, providing functional readouts of proteasome activity. These assays are used to evaluate inhibitors and mutations.
Imaging and Localization
Fluorescence microscopy of tagged proteasome subunits reveals dynamic localization and assembly in live cells. Super-resolution imaging can resolve 20S and 19S particles.
CRISPR Screens
Genome-wide CRISPR knockout screens identify genes required for proteasome function and cell survival, revealing essential subunits and assembly factors.
How CRISPR Can Be Used to Study GO:0000502 proteasome complex
Knockout
CRISPR knockout of proteasome subunit genes (e.g., PSMB5, PSMC1) in cell lines abolishes complex function and causes lethality or severe growth defects, enabling studies of subunit essentiality. Conditional knockout models can bypass early lethality.
Point Mutation
Point mutations in catalytic beta subunits (e.g., PSMB5 A49T) confer resistance to proteasome inhibitors and are used to dissect drug-binding mechanisms. CRISPR-mediated point mutation knock-in allows precise modeling of clinical mutations.
Knock-in
Knock-in of fluorescent or affinity tags (e.g., GFP, HA) into endogenous proteasome subunit loci enables live-cell imaging and proteomic analysis of the complex. Tagged knock-in models preserve endogenous regulation.
Overexpression
Overexpression of proteasome subunits or assembly chaperones can increase proteasome capacity and is used to study proteostasis and drug resistance. Lentiviral overexpression models are common.
How EDITGENE Supports proteasome complex Research
Researchers studying proteasome complex-related genes often need to determine whether a candidate gene is causally involved in proteasome assembly, activity or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for proteasome complex research.
Frequently Asked Questions About proteasome complex
What is the proteasome complex GO:0000502?
It is a large multisubunit protease that catalyzes protein degradation in eukaryotes, archaea and some bacteria, consisting of a 20S core and 19S regulatory particles.
What genes are involved in the proteasome complex?
Key genes include PSMA1, PSMB5, PSMC1, PSMD1, POMP and assembly chaperones PSMG1-4.
What is the function of the 26S proteasome?
It degrades ubiquitinated proteins in an ATP-dependent manner, regulating cell cycle, apoptosis and immune responses.
How is the proteasome complex assembled?
Assembly requires dedicated chaperones such as PAC1-PAC4, POMP and UMP1, which facilitate ordered formation of the 20S core.
What diseases are linked to proteasome dysfunction?
Cancer, neurodegenerative diseases and autoinflammatory syndromes are associated with proteasome dysfunction.
How can I study proteasome complex in the lab?
Methods include CRISPR knockout, point mutation knock-in, proteomics, activity assays and imaging.
What are proteasome inhibitors used for?
They are used to treat multiple myeloma and mantle cell lymphoma by blocking proteasome activity.
What is the difference between 20S and 26S proteasome?
The 20S core is the catalytic barrel; the 26S proteasome includes the 20S core plus one or two 19S regulatory particles.
How does CRISPR help study proteasome genes?
CRISPR enables knockout, point mutation, knock-in and overexpression of proteasome genes to dissect their functions.
What is the proteasome bounce-back response?
It is a transcriptional feedback mechanism that upregulates proteasome subunit genes upon proteasome inhibition, mediated by Nrf1.
Conclusion
The proteasome complex (GO:0000502) is a central regulator of protein degradation with essential roles in cell cycle, immunity and proteostasis. Its dysfunction is linked to cancer, neurodegeneration and autoinflammatory diseases, making it a prime therapeutic target. Advances in CRISPR-based models and proteomic methods continue to unravel its assembly, regulation and disease relevance. EDITGENE offers comprehensive services to support proteasome research, from knockout cell lines to CRISPR library screening.
References
- 1. Bard JAM et al.. 2018. Structure and Function of the 26S Proteasome.. Annu Rev Biochem 87:697-724 PMID: 29652515
- 2. Collins GA et al.. 2017. The Logic of the 26S Proteasome.. Cell 169(5):792-806 PMID: 28525752
- 3. Bogyo M et al.. 2002. Proteasome inhibitors: complex tools for a complex enzyme.. Curr Top Microbiol Immunol 268:185-208 PMID: 12083006
- 4. Gu ZC et al.. 2014. Proteasome assembly.. Cell Mol Life Sci 71(24):4729-45 PMID: 25107634
- 5. Huang L et al.. 2005. Comprehensive mass spectrometric analysis of the 20S proteasome complex.. Methods Enzymol 405:187-236 PMID: 16413316
- 6. Bochtler M et al.. 1999. The proteasome.. Annu Rev Biophys Biomol Struct 28:295-317 PMID: 10410804
- 7. Dahlmann B. 2005. Proteasomes.. Essays Biochem 41:31-48 PMID: 16250896
- 8. Enenkel C. 2014. Proteasome dynamics.. Biochim Biophys Acta 1843(1):39-46 PMID: 23545412
